KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Gross Margin (2016 - 2025)

Historic Gross Margin for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to 37.75%.

  • West Pharmaceutical Services' Gross Margin rose 12100.0% to 37.75% in Q4 2025 from the same period last year, while for Dec 2025 it was 35.91%, marking a year-over-year increase of 14000.0%. This contributed to the annual value of 35.91% for FY2025, which is 14000.0% up from last year.
  • Latest data reveals that West Pharmaceutical Services reported Gross Margin of 37.75% as of Q4 2025, which was up 12100.0% from 36.58% recorded in Q3 2025.
  • Over the past 5 years, West Pharmaceutical Services' Gross Margin peaked at 43.55% during Q2 2021, and registered a low of 32.76% during Q2 2024.
  • Its 5-year average for Gross Margin is 37.87%, with a median of 37.93% in 2023.
  • Per our database at Business Quant, West Pharmaceutical Services' Gross Margin surged by 65600bps in 2021 and then tumbled by -59000bps in 2024.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' Gross Margin stood at 41.13% in 2021, then decreased by -10bps to 36.98% in 2022, then increased by 3bps to 38.01% in 2023, then fell by -4bps to 36.54% in 2024, then increased by 3bps to 37.75% in 2025.
  • Its Gross Margin stands at 37.75% for Q4 2025, versus 36.58% for Q3 2025 and 35.73% for Q2 2025.